Rémy Cointreau SA (REMYY) Q4 2026 Sales/Trading Call Transcript

Rémy Cointreau reported Q4 organic sales growth of 8.9%, including a 4-point Chinese New Year calendar benefit, driven by Cognac sales up 15.5% organically. Liqueurs & Spirits were broadly flat at -0.1%, with strength in the U.S. and China offset by weaker EMEA trends and phasing effects. The company highlighted mix-led pricing gains of 11.3% and volume down 2.4%, pointing to resilient premium demand.

Analysis

The key takeaway is not the headline growth itself, but the composition: pricing/mix is doing nearly all the heavy lifting while volumes remain soft. That is usually a late-cycle signal in spirits, where premiumization can mask underlying demand erosion for a few quarters, but eventually creates a gap between reported revenue and depletion reality. The near-term winner is the premium cognac franchise; the loser is the broader portfolio, where weaker elasticity in liqueurs/spirits suggests consumers are trading up selectively rather than broadly expanding basket spend.

The second-order effect is on competitors and channel partners. If China duty-free disruption has normalized, the incremental lift is easier to replicate than true demand growth, so peers with more exposed travel-retail channels may not see the same benefit once comps toughen. In the U.S., high comps plus phasing issues imply the Americas deceleration could persist for 1-2 quarters, which matters because margin leverage from price is more fragile if shipment timing is doing part of the work.

The contrarian view is that the market may be underestimating how long luxury spirits can sustain price/mix even with flat-to-down volume, especially if inventory in distribution is lean. But that also means the stock is vulnerable if the next two readouts show volume still negative while price decelerates; that would expose a classic “revenue okay, earnings quality weak” setup. The reversal trigger is a normalization of China demand after the holiday boost, which could quickly turn a good Q4 into a peak-growth quarter rather than a new trend.

From a timing perspective, this looks tradable over the next 4-8 weeks into any post-print strength, with upside limited unless there is evidence of sustained sell-through. The better expression is not outright long, but a relative-value stance against other premium consumer names with less price leverage and more volume sensitivity.

Key Decisions for Investors

• Short REMYY on any post-earnings strength over the next 1-3 sessions; use a 5-7% trailing stop, targeting a fade if the market starts discounting Q1 normalization and weaker volume quality.
• Pair trade: long REMYY vs short a more volume-dependent premium consumer name in Europe/spirits over 1-3 months; the thesis is that pricing power remains intact even if unit growth mean-reverts.
• Avoid chasing the print with a directional long unless management guides to sustained China sell-through; if you must own it, use call spreads rather than stock to cap downside from a volume deceleration surprise.
• Set a catalyst watch for the next quarterly update in 6-10 weeks: if price/mix moderates while volume stays negative, expect the market to de-rate the multiple on earnings-quality concerns.